Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US FDA finalizes SOP on communicating immediate changes in medtech reg expectations

This article was originally published in Clinica

Executive Summary

The US FDA's Center for Devices and Radiological Health has finalized a new process for rapidly informing stakeholders of any changes in the center's regulatory expectations that could affect data submitted as part of a pre-market submission or an investigational device exemption.

Advertisement

Topics

UsernamePublicRestriction

Register